SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 1465.52 millions.The Net Profit of the company registered a slight decline of -25.92% to Rs. 207.70  millions from Rs. 280.39 millions.A decline of 326.34 millions was observed in the OP in the quarter ended December 2024 from 406.78 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1465.52 1464.49 0.07 4550.48 4380.57 3.88 5805.50 5103.09 13.76
Other Income 89.70 110.18 -18.59 293.57 274.04 7.13 344.22 224.84 53.10
PBIDT 326.34 406.78 -19.77 1041.32 1089.26 -4.40 1343.30 1116.50 20.31
Interest 7.28 1.55 369.68 15.16 9.64 57.26 14.63 20.29 -27.90
PBDT 319.06 405.23 -21.26 1026.16 1079.62 -4.95 1328.67 1096.21 21.21
Depreciation 32.24 28.14 14.57 96.72 79.39 21.83 106.25 91.66 15.92
PBT 286.82 377.09 -23.94 929.44 1000.23 -7.08 1222.42 1004.55 21.69
TAX 79.12 96.70 -18.18 221.71 253.17 -12.43 289.38 275.56 5.02
Deferred Tax -1.33 24.60 -105.41 34.95 39.87 -12.34 34.95 15.86 120.37
PAT 207.70 280.39 -25.92 707.73 747.06 -5.26 933.04 728.99 27.99
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 22.27 27.78 -19.83 22.88 24.87 -7.97 23.14 21.88 5.76

Lincoln Pharma Share Price

671.50 -0.75 (-0.11%)
07-May-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.90
Dr. Reddys Lab 1308.00
Cipla 1371.30
Zydus Lifesciences 939.15
Lupin 2467.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×